Table: SymBio Pharmaceuticals -Q1 group results

SymBio Pharmaceuticals

11/05/2022 07:30

May 11 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2022        Mar 31, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               2.32                                 10.99    
  Operating          509 mln                                1.77    
  Recurring          478 mln                                1.75    
  Net                163 mln                                1.48    
  EPS               4.25 yen                             38.55 yen  
  EPS Diluted       4.18 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T